Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Purpura fulminans is a rare, severe, and life-threatening condition characterized by sudden onset of skin necrosis (tissue death) and disseminated intravascular coagulation (widespread blood clotting throughout the body). This acute thrombotic disorder can occur due to congenital protein deficiencies that affect the body's natural anticoagulation system.
This test measures the level of free Protein S antigen in the blood, a natural anticoagulant protein that helps prevent excessive blood clot formation. Purpura fulminans can occur in individuals with congenital Protein S deficiency, and low levels of free Protein S antigen can indicate this underlying condition that predisposes to the severe thrombotic complications seen in purpura fulminans.
While purpura fulminans is initially recognized by its distinctive clinical presentation, blood testing is fundamental for identifying the underlying cause, particularly congenital protein deficiencies. Testing specific anticoagulant proteins helps confirm the diagnosis and guides appropriate treatment strategies to prevent further complications.
Protein S is a natural anticoagulant that works alongside Protein C to regulate blood clotting. When Protein S levels are deficient, the body's ability to control clot formation is compromised, potentially leading to the catastrophic clotting seen in purpura fulminans. Identifying this deficiency through testing is crucial for both acute management and preventing future episodes.
Purpura fulminans is a medical emergency requiring immediate treatment. The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.